QDOT MICRO versus THERMOCOOL SMARTTOUCH and THERMOCOOL SMARTTOUCH Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation

Aim: The objective of this study was to indirectly compare QDOT MICRO™ (QDOT), Thermocool R SmartTouch™ (ST) and Thermocool R SmartTouch R Surround Flow (STSF) to treat paroxysmal atrial fibrillation. Methods: Differences in baseline characteristics between study cohorts were reduced by reweighting...

Full description

Saved in:
Bibliographic Details
Main Authors: Jose Osorio (Author), Sonia Maccioni (Author), Reecha Sharma (Author), Leena Patel (Author), Paul Spin (Author), Andrea Natale (Author)
Format: Book
Published: Becaris Publishing Limited, 2023-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3e343f6678a94ac49b0d99e94e3d9b18
042 |a dc 
100 1 0 |a Jose Osorio  |e author 
700 1 0 |a Sonia Maccioni  |e author 
700 1 0 |a Reecha Sharma  |e author 
700 1 0 |a Leena Patel  |e author 
700 1 0 |a Paul Spin  |e author 
700 1 0 |a Andrea Natale  |e author 
245 0 0 |a QDOT MICRO versus THERMOCOOL SMARTTOUCH and THERMOCOOL SMARTTOUCH Surround Flow in radiofrequency ablation of paroxysmal atrial fibrillation 
260 |b Becaris Publishing Limited,   |c 2023-08-01T00:00:00Z. 
500 |a 10.57264/cer-2023-0005 
500 |a 2042-6313 
520 |a Aim: The objective of this study was to indirectly compare QDOT MICRO™ (QDOT), Thermocool R SmartTouch™ (ST) and Thermocool R SmartTouch R Surround Flow (STSF) to treat paroxysmal atrial fibrillation. Methods: Differences in baseline characteristics between study cohorts were reduced by reweighting patients using inverse probability of treatment weighting. The primary outcome was procedure time. Secondary outcomes were fluoroscopy time, clinical success at 12 months, and rhythm monitoring-adjusted recurrence. Results: QDOT was associated with significantly faster mean procedure and fluoroscopy time, and significant improvement in the rate of recurrence compared with pooled ST/STSF. No difference was observed for clinical success at 12 months. Conclusion: QDOT was associated with greater efficiency, greater effectiveness in rhythm monitoring-adjusted recurrence and similar effectiveness in clinical success at 12 months compared with pooled ST/STSF. 
546 |a EN 
690 |a indirect comparison 
690 |a indirect treatment comparison 
690 |a paroxysmal atrial fibrillation 
690 |a qdot 
690 |a smarttouch 
690 |a surround flow 
690 |a thermocool 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Journal of Comparative Effectiveness Research, Vol 12, Iss 9 (2023) 
787 0 |n https://doaj.org/toc/2042-6313 
856 4 1 |u https://doaj.org/article/3e343f6678a94ac49b0d99e94e3d9b18  |z Connect to this object online.